Covid-19 | Page 89 of 100 | Links Medicus Content Curation & Alerts in Medicine

At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue.

Full statement on AstraZeneca #COVID19 vaccine safety signals:
👉 https://t.co/9J6MtxXWK8 pic.twitter.com/fWGzqbjMuE

— World Health Organization (WHO) (@WHO) March 17, 2021

Opinion | “The zero-risk mentality stifling Europe is now killing its people”

18 Mar, 2021 | 09:11h | UTC

The zero-risk mentality stifling Europe is now killing its people – The Sidney Morning Herald

Related: Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)

Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19

18 Mar, 2021 | 09:05h | UTC

Thoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library

Opinion | “Oxford-AstraZeneca Vaccine Safety: Reports of blood clots after receiving the AstraZeneca COVID-19 vaccine are very likely just background events.”

18 Mar, 2021 | 09:09h | UTC

Oxford-AstraZeneca Vaccine Safety: Reports of blood clots after receiving the AstraZeneca COVID-19 vaccine are very likely just background events. – Science-Based Medicine

Just How Do Deaths Due to COVID-19 Stack Up?

18 Mar, 2021 | 09:03h | UTC

Just How Do Deaths Due to COVID-19 Stack Up? – Think Global Health

Commentary on Twitter (thread – click for more)

The Americas and Europe accounted for 80% of COVID-19 deaths globally, even though they represent only a quarter of the world's population. @ThinkGlobalHlth launches a tracker of COVID as a cause of death globally and the factors driving those trends 1/https://t.co/t6xp2yAWA4 pic.twitter.com/SJ9DRdlu1e

— Tom Bollyky (@TomBollyky) March 17, 2021

Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19

18 Mar, 2021 | 09:00h | UTC

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 – JAMA

Editorial: Outcomes for Patients Following Hospitalization for COVID-19

Why Opening Windows Is a Key to Reopening Schools

18 Mar, 2021 | 09:02h | UTC

Why Opening Windows Is a Key to Reopening Schools – The New York Times (free registration may be required)

Commentary on Twitter

https://twitter.com/trishgreenhalgh/status/1372180956094865409

COVID-19 vaccines vs. variants—determining how much immunity is enough

18 Mar, 2021 | 08:58h | UTC

COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough – JAMA

Population Study: Past Covid-19 confers 80.5% protection against reinfection, which decreases to 47.1% in those aged 65 years and older

18 Mar, 2021 | 09:06h | UTC

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study – The Lancet

Commentaries: Risk of SARS-CoV-2 reinfection after natural infection – The Lancet AND COVID-19 Reinfection: More Common Than We Think? – MedPage Today (free registration required)

Commentary on Twitter

NEW—Most people who have had original #COVID19 strain are protected from catching it again for at least 6 months—but those ≥65 years are more prone to reinfection, suggests first large-scale study of its kind. Read https://t.co/250Yv0a9BZ pic.twitter.com/BTjhcMzXwT

— The Lancet (@TheLancet) March 17, 2021

[Preprint] Delaying second vaccine dose leaves cancer patients vulnerable to virus

17 Mar, 2021 | 02:58h | UTC

News release: Delaying second vaccine dose leaves cancer patients vulnerable to virus – King’s College London

Commentaries: Expert reaction to preprint looking at antibody immune response following one dose of Pfizer COVID-19 vaccine in cancer patients – Science Media Centre AND Cancer patients ‘lack same protection’ after first jab – BBC

WHO points to wildlife farms in southern China as likely source of pandemic

17 Mar, 2021 | 03:02h | UTC

WHO Points To Wildlife Farms In Southern China As Likely Source Of Pandemic – wbur

WHO: New research highlights risks of separating newborns from mothers during COVID-19 pandemic

17 Mar, 2021 | 03:04h | UTC

New research highlights risks of separating newborns from mothers during COVID-19 pandemic – World Health Organization

Original study: Preterm care during the COVID-19 pandemic: A comparative risk analysis of neonatal deaths averted by kangaroo mother care versus mortality due to SARS-CoV-2 infection – EclinicalMedicine

Immunogenicity of a single dose of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients

17 Mar, 2021 | 02:55h | UTC

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients – JAMA

RCT: Oxford/AstraZeneca vaccine does not protect against mild-to-moderate Covid-19 due to the B.1.351 variant

17 Mar, 2021 | 03:01h | UTC

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant – New England Journal of Medicine

Commentaries: AstraZeneca vaccine doesn’t prevent B1351 COVID in early trial – CIDRAP AND Oxford/AstraZeneca Fails to Prevent Mild to Moderate Covid-19 From B.1.351 (“South Africa”) Variant – Brief19

FDA: Why you should not use Ivermectin to treat or prevent COVID-19

17 Mar, 2021 | 02:51h | UTC

Why You Should Not Use Ivermectin to Treat or Prevent COVID-19 – U.S. Food & Drug Administration

Commentary: FDA Rejects Ivermectin, Despite Growing Interest In Some Corners Of The Internet – Brief19

COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies

17 Mar, 2021 | 02:52h | UTC

COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies – Cochrane Library

Commentary on Twitter

How common are pre‐existing heart & blood vessel problems in #COVID19? What are most common complications affecting heart & blood vessels in #COVID19? @CochraneHeart review of prevalence studies: https://t.co/rDqz2GyrpH

— The Cochrane Library (@CochraneLibrary) March 12, 2021